PD10-10 RACIAL DISPARITIES IN DELIVERING DEFINITIVE THERAPY FOR INTERMEDIATE-HIGH RISK LOCALIZED PROSTATE CANCER: THE IMPACT OF FACILITY FEATURES AND SOCIOECONOMIC CHARACTERISTICS

Abstract

You have accessJournal of UrologyProstate Cancer: Localized: Surgical Therapy I1 Apr 2017PD10-10 RACIAL DISPARITIES IN DELIVERING DEFINITIVE THERAPY FOR INTERMEDIATE-HIGH RISK LOCALIZED PROSTATE CANCER: THE IMPACT OF FACILITY FEATURES AND SOCIOECONOMIC CHARACTERISTICS David F. Friedlander, Nicolas von Landenberg, Philipp Gild, Quoc-Dien Trinh, Patrick Karabon, Maxine Sun, Paul L. Nguyen, Adam S. Kibel, Toni K. Choueiri, Joel S. Weissman, Mani Menon, and Firas Abdollah David F. FriedlanderDavid F. Friedlander More articles by this author , Nicolas von LandenbergNicolas von Landenberg More articles by this author , Philipp GildPhilipp Gild More articles by this author , Quoc-Dien TrinhQuoc-Dien Trinh More articles by this author , Patrick KarabonPatrick Karabon More articles by this author , Maxine SunMaxine Sun More articles by this author , Paul L. NguyenPaul L. Nguyen More articles by this author , Adam S. KibelAdam S. Kibel More articles by this author , Toni K. ChoueiriToni K. Choueiri More articles by this author , Joel S. WeissmanJoel S. Weissman More articles by this author , Mani MenonMani Menon More articles by this author , and Firas AbdollahFiras Abdollah More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.573AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The gap in prostate cancer (PCa) survival between Blacks and Whites has widened over the past decade. Investigators hypothesize that this disparity may be partially attributable to differences in rates of definitive therapy between races. We therefore sought to examine the variation in use of definitive therapy among Black and White men for localized PCa. METHODS Using data from the National Cancer Data Base, we identified 283,135 White and Black men >=40years of age with biopsy confirmed localized intermediate-high risk PCa diagnosed between January 2004 and December 2013. Multilevel logistic regression was fitted to predict the odds of receiving definitive therapy for PCa. Sensitivity and subgroup analyses were performed to adjust for inherent patient and facility-level differences. RESULTS 82.9% (n=185,647) of White men received definitive therapy compared to 73.7% (n=43,662) of Black men over a 10-year period. Overall rates of definitive therapy during that time increased for both White (81.3% vs. 83.3%, p<0.001) and Black (72.8% vs. 75.4%, p=0.001) men. However, 38.5% of treating facilities demonstrated significantly higher rates of definitive therapy in White men, compared to just 0.8% of facilities favoring Black men. CONCLUSIONS After adjusting for sociodemographic and clinical factors, we found significant facility-level variation in rates of definitive therapy for intermediate-high risk localized PCa among White and Black men, with most facilities favoring therapy in Whites. Our study is limited by the retrospective nature of the cohort. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e203-e204 Advertisement Copyright & Permissions© 2017MetricsAuthor Information David F. Friedlander More articles by this author Nicolas von Landenberg More articles by this author Philipp Gild More articles by this author Quoc-Dien Trinh More articles by this author Patrick Karabon More articles by this author Maxine Sun More articles by this author Paul L. Nguyen More articles by this author Adam S. Kibel More articles by this author Toni K. Choueiri More articles by this author Joel S. Weissman More articles by this author Mani Menon More articles by this author Firas Abdollah More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...